The heparin assay controls may run longer than normal and in some cases, fail to give an acceptable result.
Source facts
Action
Medtronic issued an "Urgent Medical Device Notification" letter dated March 8, 2010 addressed to "Dear Valued Customer" and was sent to three locations at each customer site: Risk Management, Cardiovascular Surgery and Clinical Laboratory-Point of Care. The letter described the product and the issue, provided instructions for control and patient testing. The customer was requested to return an enclosed certificate as proof of notification.
For further information, contact your Medtronic Sales Representative or call 1-763-391-9915.
Initiated
2010-03-08
Root cause
Process change control
Terminated
2011-12-31
Distribution
Worldwide Distribution -- United States, International West (countries included in Western Europe and the Middle East), Australia and Canada.
Recall number
Z-1537-2010
Recall status
Terminated
CDRH record ID
90214
FDA classified
2010-05-04
Recall event number
55169
Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.
Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.